Cargando…
Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers
Diabetes mellitus is characterized by a lack of insulin causing elevated blood glucose, often with associated insulin resistance. Over time, especially in genetically susceptible individuals, such chronic hyperglycemia can cause tissue injury. One pathological response to tissue injury is the develo...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515418/ https://www.ncbi.nlm.nih.gov/pubmed/18827908 |
_version_ | 1782158425053986816 |
---|---|
author | Ban, Camelia R Twigg, Stephen M |
author_facet | Ban, Camelia R Twigg, Stephen M |
author_sort | Ban, Camelia R |
collection | PubMed |
description | Diabetes mellitus is characterized by a lack of insulin causing elevated blood glucose, often with associated insulin resistance. Over time, especially in genetically susceptible individuals, such chronic hyperglycemia can cause tissue injury. One pathological response to tissue injury is the development of fibrosis, which involves predominant extracellular matrix (ECM) accumulation. The main factors that regulate ECM in diabetes are thought to be pro-sclerotic cytokines and protease/anti-protease systems. This review will examine the key markers and regulators of tissue fibrosis in diabetes and whether their levels in biological fluids may have clinical utility. |
format | Text |
id | pubmed-2515418 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-25154182008-10-01 Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers Ban, Camelia R Twigg, Stephen M Vasc Health Risk Manag Review Diabetes mellitus is characterized by a lack of insulin causing elevated blood glucose, often with associated insulin resistance. Over time, especially in genetically susceptible individuals, such chronic hyperglycemia can cause tissue injury. One pathological response to tissue injury is the development of fibrosis, which involves predominant extracellular matrix (ECM) accumulation. The main factors that regulate ECM in diabetes are thought to be pro-sclerotic cytokines and protease/anti-protease systems. This review will examine the key markers and regulators of tissue fibrosis in diabetes and whether their levels in biological fluids may have clinical utility. Dove Medical Press 2008-06 2008-06 /pmc/articles/PMC2515418/ /pubmed/18827908 Text en © 2008 Ban and Twigg, publisher and licensee Dove Medical Press Ltd. |
spellingShingle | Review Ban, Camelia R Twigg, Stephen M Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers |
title | Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers |
title_full | Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers |
title_fullStr | Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers |
title_full_unstemmed | Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers |
title_short | Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers |
title_sort | fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515418/ https://www.ncbi.nlm.nih.gov/pubmed/18827908 |
work_keys_str_mv | AT bancameliar fibrosisindiabetescomplicationspathogenicmechanismsandcirculatingandurinarymarkers AT twiggstephenm fibrosisindiabetescomplicationspathogenicmechanismsandcirculatingandurinarymarkers |